Advanced in Fibrolamellar Carcinoma

Karl-heinz H. Weiss

Heidelberg, BW, DE 
Advanced in Fibrolamellar Carcinoma
Heidelberg, BW, DE 
OverviewLocationsClinical Research

Overview

Karl-heinz Weiss practices in Heidelberg, Germany. Weiss is rated as an Advanced expert by MediFind in the treatment of Fibrolamellar Carcinoma. Their top areas of expertise are Hepatocerebral Degeneration, Wilson Disease, Fibrolamellar Carcinoma, Liver Transplant, and Liver Embolization.

Their clinical research consists of co-authoring 34 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Fibrolamellar Carcinoma.

Locations

Heidelberg, BW 69120, Germany
Other Locations
Braunschweig, NI, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3, Randomized, Rater-Blinded, Multi-Center Study to Evaluate the Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Patients With Wilson Disease Aged 12 Years and Older, With an Extension Period of up to 60 Months
A Phase 3, Randomized, Rater-Blinded, Multi-Center Study to Evaluate the Efficacy and Safety of ALXN1840 Administered for 48 Weeks Versus Standard of Care in Patients With Wilson Disease Aged 12 Years and Older, With an Extension Period of up to 60 Months
Enrollment Status: Terminated
Publish Date: June 17, 2024
Intervention Type: Drug
Study Drug: ALXN1840
Study Phase: Phase 3

34 Total Publications

Comparative proteomics reveals different protein expression in platelets in patients with alcoholic liver cirrhosis.
Comparative proteomics reveals different protein expression in platelets in patients with alcoholic liver cirrhosis.
Journal: Proteome science
Published: October 16, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Weiss's expertise for a condition
ConditionClose
    View All 17 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile